미국과 한국에서 NeuroMatch가 출시되었습니다. 더 알아보기:

EEG Breakthrough: LVIS Corporation Unveils AI Platform That Streamlines Ambulatory Review Workflow

Palo Alto, CA — June 24, 2025 —  LVIS Corporation has announced a major enhancement to its unparalleled NeuroMatch® platform with the release of full ambulatory EEG capability—an advancement that promises to streamline one of the most cumbersome and time-intensive processes in neurology.

Ambulatory EEG is a critical tool for diagnosing complex neurological conditions like epilepsy, capturing continuous brain activity while patients go about their daily lives over a period of several days. However, the traditional review process is notoriously complex, generating tens of thousands of EEG segments per study that must be manually reviewed by specialists.

Now, with NeuroMatch’s new ambulatory EEG functionality, LVIS is eliminating many of the inefficiencies that have historically burdened clinicians. 

The AI-powered platform rapidly analyzes large data sets, automatically identifies and flags relevant neurological events, and filters out common artifacts such as muscle or eye movements—all in a browser-based interface that requires no downloads, installations, or dedicated hardware.

“Ambulatory EEG is essential, but it’s been incredibly resource-intensive for both physicians and technicians,” said Jin Hyung Lee, Founder of LVIS Corporation. “With this NeuroMatch update, we’ve built an intelligent, streamlined experience that lets clinicians focus only on what matters most—making faster, more confident diagnoses.”

This expanded capability will allow healthcare providers to launch, monitor, and interpret ambulatory EEG studies from any internet-connected device, at any time. Physicians can start a review in the hospital, continue from home, and finalize reports from their office—all without interrupting workflow or toggling between systems. Reports can be signed, summarized, and delivered within the same platform. Cloud-based infrastructure allows teams to collaborate across facilities without compromising quality or data consistency.

Designed with clinical efficiency in mind, NeuroMatch features seizure and spike trend visualizations, customizable report templates, daily summaries, integrated annotations, and secure digital signatures. These features are built to reflect and enhance the way neurologists already work—delivering smarter diagnostics without additional complexity.

As more healthcare moves beyond the hospital, NeuroMatch’s advanced ambulatory EEG functionality offers a scalable and intuitive solution that keeps pace with modern demands—helping providers deliver better care in real-world settings.To learn more about how NeuroMatch is transforming EEG diagnostics, visit www.lviscorp.com.

댓글 남기기

Join the
LVIS NeuroMatch Newsletter

Subscribe to our newsletter and stay updated on the latest innovations, awards, and events you won't want to miss!

No thanks